Pharmaceutical composition for treating macular degeneration comprising an imidazoline derivative compound as an active ingredient

• Main Author: KIM CHAEKYU
• Format: Patent
• Language: English; Korean
• Published: 11.11.2022
• Subjects: FOODS OR FOODSTUFFS; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES

The present invention relates to a pharmaceutical composition for treating macular degeneration, containing an imidazoline derivative compound as an active ingredient. A composition containing an imidazoline derivative compound or a pharmaceutically acceptable salt thereof as an active ingredient, according to one aspect, selectively kills senescent cells to reduce drusen and macular atrophy, and thus can be effectively used for preventing and/or treating macular degeneration. 이미다졸린 유도체 화합물을 유효성분으로 포함하는 황반 변성 치료용 약학적 조성물에 관한 것으로, 일 양상에 따른 이미다졸린 유도체 화합물 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 조성물에 의하면, 노화세포를 선택적으로 사멸시켜 드루젠와 황반 위축이 감소되어 황반 변성의 예방 및/또는 치료에 유용하게 사용될 수 있는 효과가 있다.